Mark S. Schroeder - 04 Feb 2022 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role: EVP, President-Diagnostics Lab
Signature: /s/ Sandra D. van der Vaart, Attorney-in-Fact for Mark S. Schroeder
Issuer symbol: LH
Transactions as of: 04 Feb 2022
Net transactions value: -$98,762
Form type: 4
Filing time: 08 Feb 2022, 10:08:32 UTC
Previous filing: 04 Feb 2022
Next filing: 15 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LH	Common Stock	Options Exercise		+560	+8.7%		6,961	04 Feb 2022	Direct	F1
transaction	LH	Common Stock	Tax liability	$42,177	-152	-2.2%	$277.48	6,809	04 Feb 2022	Direct	F2
transaction	LH	Common Stock	Sale	$56,586	-204	-3%	$277.38	6,605	07 Feb 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LH	Restricted Stock Unit	Options Exercise	$0	-560	-13%	$0.000000	3,741	04 Feb 2022	Common Stock	560		Direct	F1, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2	Stock withholding to satisfy tax withholding obligations.
F3	Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
F4	The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 4, 2021.
F5	This number reflects the aggregate number of Restricted Stock Units held by the reporting person.